Reply to Watchorn : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.
作者信息
Foer Dinah, Beeler Patrick E, Cui Jing, Karlson Elizabeth W, Bates David W, Cahill Katherine N
机构信息
Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.
Brigham and Women's Hospital Boston, Massachusetts.
出版信息
Am J Respir Crit Care Med. 2021 Apr 1;203(7):924-925. doi: 10.1164/rccm.202012-4511LE.
Abstract
摘要
相似文献
1
Reply to Watchorn : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.对沃乔恩的回复：2型糖尿病患者使用胰高血糖素样肽-1受体激动剂时的哮喘加重情况
Am J Respir Crit Care Med. 2021 Apr 1;203(7):924-925. doi: 10.1164/rccm.202012-4511LE.
2
Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.使用胰高血糖素样肽-1受体激动剂治疗2型糖尿病患者的哮喘急性加重情况
Am J Respir Crit Care Med. 2021 Apr 1;203(7):923-924. doi: 10.1164/rccm.202011-4162LE.
3
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对阿尔博加米等人的评论。2型糖尿病患者中胰高血糖素样肽1受体激动剂与慢性下呼吸道疾病急性加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e165-e166. doi: 10.2337/dc21-0904. Epub 2021 Jul 20.
4
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对关于阿尔博加米等人的评论的回应。2型糖尿病患者中胰高血糖素样肽-1受体激动剂与慢性下呼吸道疾病加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e167. doi: 10.2337/dci21-0024. Epub 2021 Jul 20.
5
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.胰高血糖素样肽-1及其受体激动剂：它们在2型糖尿病管理中的作用。
Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15.
6
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.新型 2 型糖尿病治疗药物 第 2 部分：胰高血糖素样肽-1（GLP-1）激动剂。
Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2.
7
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.胰高血糖素样肽-1受体激动剂对2型糖尿病患者体重减轻的影响：一项系统评价与混合治疗比较的Meta分析
PLoS One. 2015 Jun 29;10(6):e0126769. doi: 10.1371/journal.pone.0126769. eCollection 2015.
8
Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂治疗患者的严重急性肾衰竭。
Diabetes Res Clin Pract. 2014 Mar;103(3):e53-5. doi: 10.1016/j.diabres.2013.11.014. Epub 2013 Nov 20.
9
Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review.吸烟、2 型糖尿病与胰高血糖素样肽-1 受体激动剂作为糖尿病吸烟者的潜在治疗方法：综合评价。
Diabetes Res Clin Pract. 2019 Mar;149:78-88. doi: 10.1016/j.diabres.2019.01.033. Epub 2019 Feb 5.
10
Overview of Glucagon-like Peptide-1 Receptor Agonists.胰高血糖素样肽-1受体激动剂概述
Home Healthc Now. 2015 Nov-Dec;33(10):538-44. doi: 10.1097/NHH.0000000000000312.
引用本文的文献
1
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023.肥胖、免疫与炎症：健康与疾病中的相互关系：第 24 届哈佛营养肥胖研讨会报告，2023 年 6 月。
Am J Clin Nutr. 2024 Jul;120(1):257-268. doi: 10.1016/j.ajcnut.2024.04.029. Epub 2024 May 3.
本文引用的文献
1
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.2 型糖尿病合并哮喘患者使用胰高血糖素样肽-1 受体激动剂后哮喘加重。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):831-840. doi: 10.1164/rccm.202004-0993OC.
2
Glycated Hemoglobin A, Lung Function, and Hospitalizations Among Adults with Asthma.糖化血红蛋白A、肺功能与哮喘成年患者的住院情况
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3409-3415.e1. doi: 10.1016/j.jaip.2020.06.017. Epub 2020 Jun 20.
3
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.哮喘加重倾向的证据和加重频率的预测生物标志物。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):973-982. doi: 10.1164/rccm.201909-1813OC.
4
Association of Metformin Initiation and Risk of Asthma Exacerbation. A Claims-based Cohort Study.二甲双胍起始治疗与哮喘恶化风险的相关性：基于索赔数据的队列研究。
Ann Am Thorac Soc. 2019 Dec;16(12):1527-1533. doi: 10.1513/AnnalsATS.201812-897OC.
5
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.胰高血糖素样肽 1 信号抑制变应原诱导的肺 IL-33 释放，并减少体内 2 型先天淋巴细胞细胞因子的产生。
J Allergy Clin Immunol. 2018 Nov;142(5):1515-1528.e8. doi: 10.1016/j.jaci.2017.11.043. Epub 2018 Jan 10.
6
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.血浆白细胞介素-6 浓度、代谢功能障碍与哮喘严重程度：两个队列的横断面分析。
Lancet Respir Med. 2016 Jul;4(7):574-584. doi: 10.1016/S2213-2600(16)30048-0. Epub 2016 Jun 6.
Zotero 插件